Related Experiment Video

Updated: Aug 24, 2026

Point-of-Care Lung Ultrasound in Adults: Image Acquisition
09:17

Point-of-Care Lung Ultrasound in Adults: Image Acquisition

Published on: March 3, 2023

Shooting for PARs in lung diseases

James D Moffatt1, Clive P Page, Geoffrey J Laurent

  • 1Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, Guy's Campus, King's College London, London SE1 1UL, UK.

Current Opinion in Pharmacology
|May 14, 2004
PubMed

Insights

Proteinase-activated receptors (PARs) are crucial in lung diseases. Further research is needed to understand PAR functions in the lungs for potential drug development.

Area of Science:

  • Immunology
  • Pharmacology
  • Cell Biology

Background:

  • Proteinase-activated receptors (PARs) are G-protein-coupled receptors activated by proteases.
  • PARs are expressed in airway cells and implicated in inflammatory lung diseases.
  • PAR activation may contribute to pathological changes in the lungs.

Purpose of the Study:

  • To highlight the role of PARs in lung diseases.
  • To emphasize the need for further research into PAR functions in the lung.

Main Methods:

  • Review of existing in vitro studies.
  • Analysis of current pharmacological tools.

Main Results:

  • PARs are present in various airway cell types relevant to lung inflammation.
  • PAR activation is linked to pathological changes in lung diseases.

Conclusions:

  • PARs represent promising therapeutic targets for lung diseases.
  • More in vivo research is required to fully establish PARs as drug targets due to limitations in current data and tools.

More Related Videos

Vascular Casting of Adult and Early Postnatal Mouse Lungs for Micro-CT Imaging09:00

Vascular Casting of Adult and Early Postnatal Mouse Lungs for Micro-CT Imaging

Published on: June 20, 2020

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: